Misdosing Incident Prompts Astellas To Change Muscle Relaxant Succin Name
This article was originally published in PharmAsia News
Executive Summary
A death caused by drug misdosing in Japan has prompted Astellas to change the name for muscle relaxant Succin (suxamethonium) injection. Last November, a patient died after a hospital in Tokushima Prefecture mistakenly administrated Succin to the patient, who was originally prescribed antibacterial Saxizon (hydrocortisone sodium succinate) by Kowa Pharmaceutical. The incident prompted Japan's Ministry of Health, Labor and Welfare to put out a notice to Astellas and nationwide medical facilities. Astellas will now market the drug with its generic name. (Click here for more - Japanese language